Friedrich Wimazal

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz et al. · Blood · 2007 · 783 citations · Full text

Diagnostic and Subdiagnostic Accumulation of Mast Cells in the Bone Marrow of Patients with Anaphylaxis: Monoclonal Mast Cell Activation Syndrome

Karoline Sonneck, Stefan Florian, Leonhard Müllauer et al. · International Archives of Allergy and Immunology · 2006 · 126 citations

Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group

Wolfgang R. Sperr, Friedrich Wimazal, Michael Kundi et al. · Annals of Oncology · 2009 · 115 citations · Full text

Prognostic Evaluation, Psychiatry, Prognosis +8

The <i><scp>KIT</scp></i><scp>D</scp>816<scp>V</scp> allele burden predicts survival in patients with mastocytosis and correlates with the <scp>WHO</scp> type of the disease

Gregor Hoermann, Karoline V. Gleixner, Graziella E. Dinu et al. · Allergy · 2014 · 97 citations · Full text

Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: The diagnostic interface

Friedrich Wimazal, Christa Fonatsch, Renate Thalhammer et al. · Leukemia Research · 2007 · 90 citations

Idiopathic Cytopenia, Surgical Pathology, Histopathology +8